Sen. Todd Young (R-IN), chair of the National Security Commission on Emerging Biotechnology (Ben Curtis/AP Images)
April 8, 2025 12:01 AM EDTUpdated 06:14 AM
China
Pharma

Amid Trump’s re­search cuts, com­mis­sion says US risks los­ing biotech race with­out $15B in­vest­ment

Jared Whitlock

Features Editor

A con­gres­sion­al com­mis­sion is ad­vo­cat­ing for a $15 bil­lion fed­er­al in­vest­ment in Amer­i­ca’s biotech­nol­o­gy sec­tor, warn­ing that the US could soon be eclipsed by Chi­na …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Mar­ket tur­moil is tank­ing biotech M&A and IPOs. Here's the play­book star­tups will use to sur­vive

Makary wants to re­place an­i­mal test­ing with organoids. It may take a while

Re­cruiters say some bio­phar­mas pause hir­ing as they strug­gle to make sense of on­go­ing un­cer­tain­ty

Ex­clu­sive: Meri­da Bio­sciences gets $121M to treat au­toim­mune and al­ler­gy dis­eases at their roots

Bris­tol My­er­s' im­munother­a­py com­bo nets ap­provals in col­orec­tal and liv­er can­cer

Phar­ma tar­iffs: Here’s what a po­ten­tial roll­out could look like

A service from the Financial Times